1. Home
  2. |Insights
  3. |The CY2019 Proposed Rule for Medicare Advantage and Medicare Prescription Drug Benefit Programs

The CY2019 Proposed Rule for Medicare Advantage and Medicare Prescription Drug Benefit Programs

Webinar | 12.12.17, 8:00 AM EST - 9:30 AM EST

CMS issued the long-awaited proposed rule that would make major changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs. CMS proposes many changes that are intended to increase transparency and alleviate administrative burdens on MA organizations and Part D sponsors. Other changes implement the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act. CMS also solicits comments on a number of important topics.


Please join us for a webinar during which members of our Health Care Group discuss some of the key provisions of the proposed rule.


Provisions that we will address include:

  • Implementation of the Comprehensive Addiction and Recovery Act of 2016
  • New Benefit Flexibility under Medicare Advantage
  • Tiering and Other Part D Changes
  • Changes to the Star Ratings Program and the Impact for Contract Consolidation
  • Changes to the Part C and Part D Medical Loss Ratio Requirements

Contact

Insights

Webinar | 07.24.25

Avoiding Greenwashing Liability: Sustainability and ESG Under Scrutiny

These ESG claims were purported to be overstated, misleading, or false and unsubstantiated. While these early cases focused on false advertising and consumer protection law violations, recent cases have focused more on misleading ESG funds and investment products, net-zero targets, and carbon-neutral claims, sometimes coordinating claims across jurisdictions including the EU, UK, Australia, and the U.S.